Trial Profile
A clinical trial of BioPhage-PR in cystic fibrosis patients with Pseudomonas aeruginosa lung infections.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2012
Price :
$35
*
At a glance
- Drugs AP PA01 (Primary)
- Indications Bacterial infections; Cystic fibrosis-associated respiratory tract infections
- Focus Therapeutic Use
- 18 Sep 2012 New trial record